STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock Series A [Member]	Common Stock [Member]	Stock Payable [Member]	Share Subscription Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2022	$ 5,000	$ 105,265		$ (10,000)	$ 38,957,921	$ (40,168,610)	$ (1,110,424)
Beginning balance, shares at Oct. 31, 2022	5,000,000	105,265,299
Common stock issued for cash		$ 290,000					290,000
Common stock issued for cash, shares		290,000,000
Stock-based compensation		$ 2,025			467,775		469,800
Common stock based compensation, shares		2,025,000
Common stock issued for settlement of debt		$ 20,000					20,000
Common stock issued for settlement of debt, shares		20,000,000
Regulation A stock issuances		$ 2,026	32,251	(13,750)	2,024,506		2,045,033
Regulation A stock issuances, shares		2,026,532
Commitment share issued		$ 25			19,975		20,000
Commitment share issued, shares		24,753
Net loss						(1,927,494)	(1,927,494)
Ending balance, value at Oct. 31, 2023	$ 5,000	$ 419,341	32,251	(23,750)	41,470,177	(42,096,104)	(193,085)
Ending balance, shares at Oct. 31, 2023	5,000,000	419,341,584
Regulation A stock issuances		$ 434	(17,001)		432,995		416,428
Regulation A stock issuances, shares		433,429
Regulation D stock issuances		$ 2,263			523,237		525,500
Regulation D stock issuances, shares		2,262,852
Shares cancelled as per settlement agreement - Vivaris Capital		$ (10,000)		10,000
Shares cancelled as per settlement agreement - Vivaris Capital, shares		(10,000,000)
Stock-based compensation		$ 7,400			1,184,956		1,192,356
Common stock based compensation, shares		7,400,000
Net loss						(3,338,590)	(3,338,590)
Ending balance, value at Oct. 31, 2024	$ 5,000	$ 419,438	$ 15,250	$ (13,750)	$ 43,611,365	$ (45,434,694)	$ (1,397,391)
Ending balance, shares at Oct. 31, 2024	5,000,000	419,437,865